NIHR Alert: Platform trial rules out treatments for COVID-19, NIHR

Expert commentary is provided for a trial which found adding doxycycline, azithromycin or colchicine to usual care provides no benefit to people in the community with COVID-19. These data are useful as preventing ineffective antibiotic use is critical to reduce drug resistance.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news